Inka Aho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Inka Aho has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
Pia Kivelä
University of Helsinki Faculty of Medicine
5 shared publicationsJussi Sutinen
Department of Infectious diseases, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
3 shared publications- Matti Ristola
Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland
3 shared publications A. C. Gadano
Italian Hospital of Buenos Aires Buenos Aires Argentina
2 shared publicationsA. Hatzakis
Department of Hygiene, Epidemiology and Medical Statistics Athens University Medical School Athens Greece
2 shared publicationsA. J. van der Meer
Department of Gastroenterology and Hepatology Erasmus MC University Medical Center Rotterdam The Netherlands
2 shared publications
Latest Publications
- Open Access
- 23 June 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 154, e81
New HIV diagnoses and risk factors for late HIV diagnosis, Finland, 2008–2023
Late HIV diagnosis increases morbidity and mortality. In this retrospective cohort study on the national HIV register, we analysed risk factors for late HIV diagnosis among newly registered people living with HIV (PLWH) between 2008 and 2023, using the updated definition. Of 2683 PLWH registered, 1813 (67.6%) were newly diagnosed with CD4+ T-cell count available ≤90 days for 1572 (86.7%). Eighty-seven of the 609 (14.3%) individuals with CD4+ T-cell count <350/μL had recent infections and were reclassified as non-late. Of the newly diagnosed, 50.3% were diagnosed late. Multivariable analysis identified higher age as an independent risk factor for late diagnosis (adjusted OR 1.42 per ten years, 95% CI 1.30–1.56). Of the Finnish-born, females had lower odds than males (aOR 0.59, 95% CI 0.39–0.88). Asian-born (aOR 6.83, 95% CI 3.49–13.35) and African-born females (aOR 3.26, 95% CI 1.58–6.73) had significantly higher odds than Finnish-born females. In urban municipalities, men who have sex with men had lower odds than individuals with heterosexual transmission (aOR 0.55, 95% CI 0.40–0.76). Higher age was the most important factor for increasing the proportion of late diagnoses. We recommend enhanced testing and risk awareness for older adults and migrants from high-prevalence countries.
- 23 June 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 154, e81
Open AccessNew HIV diagnoses and risk factors for late HIV diagnosis, Finland, 2008–2023
Late HIV diagnosis increases morbidity and mortality. In this retrospective cohort study on the national HIV register, we analysed risk factors for late HIV diagnosis among newly registered people living with HIV (PLWH) between 2008 and 2023, using the updated definition. Of 2683 PLWH registered, 1813 (67.6%) were newly diagnosed with CD4+ T-cell count available ≤90 days for 1572 (86.7%). Eighty-seven of the 609 (14.3%) individuals with CD4+ T-cell count <350/μL had recent infections and were reclassified as non-late. Of the newly diagnosed, 50.3% were diagnosed late. Multivariable analysis identified higher age as an independent risk factor for late diagnosis (adjusted OR 1.42 per ten years, 95% CI 1.30–1.56). Of the Finnish-born, females had lower odds than males (aOR 0.59, 95% CI 0.39–0.88). Asian-born (aOR 6.83, 95% CI 3.49–13.35) and African-born females (aOR 3.26, 95% CI 1.58–6.73) had significantly higher odds than Finnish-born females. In urban municipalities, men who have sex with men had lower odds than individuals with heterosexual transmission (aOR 0.55, 95% CI 0.40–0.76). Higher age was the most important factor for increasing the proportion of late diagnoses. We recommend enhanced testing and risk awareness for older adults and migrants from high-prevalence countries.
- Open Access
- 16 February 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 154, 1-28
Burden and risk factors of sexually transmitted infections before and after HIV diagnosis in a Finnish national HIV cohort, 1995–2019
Sexually transmitted infections (STIs) are common among people living with human immunodeficiency virus (HIV) (PLWH). This nationwide register study linked HIV and STI registries to examine STI trends before and after HIV diagnosis in Finland 1995–2019 among all PLWH residing in the country. Analysed STIs were chlamydia, gonorrhoea, syphilis, and hepatitis B and C. An extended Cox model assessed factors associated with STI events. Among 3,775 PLWH (mean follow-up 17.9 person-years), 71% had no STIs, 17% had one, and 12% had two or more. Overall, 10.7% had an STI before HIV diagnosis and 18.1% after. STI incidence was 32 per 1,000 person-years and increased over time, although chlamydia and gonorrhoea declined. STI risk was highest among men who have sex with men (MSM) and lowest among people who inject drugs; it remained stable or declined after HIV diagnosis. STIs before HIV diagnosis offer opportunities for HIV testing and pre-exposure prophylaxis promotion. As most had no STIs other than HIV, HIV testing should not be limited to STI screening but also performed in other indicator conditions. After HIV diagnosis, accessible low-threshold STI testing, particularly for MSM, and consideration of doxycycline prophylaxis may benefit those at highest risk.
- 16 February 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 154, 1-28
Open AccessBurden and risk factors of sexually transmitted infections before and after HIV diagnosis in a Finnish national HIV cohort, 1995–2019
Sexually transmitted infections (STIs) are common among people living with human immunodeficiency virus (HIV) (PLWH). This nationwide register study linked HIV and STI registries to examine STI trends before and after HIV diagnosis in Finland 1995–2019 among all PLWH residing in the country. Analysed STIs were chlamydia, gonorrhoea, syphilis, and hepatitis B and C. An extended Cox model assessed factors associated with STI events. Among 3,775 PLWH (mean follow-up 17.9 person-years), 71% had no STIs, 17% had one, and 12% had two or more. Overall, 10.7% had an STI before HIV diagnosis and 18.1% after. STI incidence was 32 per 1,000 person-years and increased over time, although chlamydia and gonorrhoea declined. STI risk was highest among men who have sex with men (MSM) and lowest among people who inject drugs; it remained stable or declined after HIV diagnosis. STIs before HIV diagnosis offer opportunities for HIV testing and pre-exposure prophylaxis promotion. As most had no STIs other than HIV, HIV testing should not be limited to STI screening but also performed in other indicator conditions. After HIV diagnosis, accessible low-threshold STI testing, particularly for MSM, and consideration of doxycycline prophylaxis may benefit those at highest risk.
- Open Access
- 25 August 2025
- Published by Wiley in HIV Medicine
- Vol. 26 (10) , 1515-1524
European Guidelines on HIV and breastfeeding: “Same, same, but different” ‐ Results from a WAVE survey
Introduction: A notable gap exists in research on HIV and breastfeeding in high‐income settings with continuous access to antiretroviral therapy (ART) and suppressed HIV viral loads. The Women Against Viruses in Europe (WAVE) initiative aimed to consolidate European guidelines on HIV and breastfeeding to better inform medical staff and people living with HIV in the decision‐making process for breastfeeding. Methods: Representatives from 23 countries were contacted by WAVE to submit their guidelines on HIV and breastfeeding, translated into English. The initial contact was made on 20 April 2023, and the final response was received on 26 May 2023. The WAVE breastfeeding group summarized the guidelines into key topics related to breastfeeding for the purpose of this manuscript. Results: A total of 19 guidelines from 20 countries were included in the review. While the majority of countries recommend formula feeding as the preferred feeding for infants born to mothers living with HIV, most provide recommendations to support parents who choose to breastfeed if certain criteria are met. Conclusion: Despite recommendations being based on the same research, there is variation across guidelines. This review consolidates European guidelines, enabling us to learn from each other and pool our experiences to create a robust cohort for further research and guideline development for parents living with HIV and their infants.
- 25 August 2025
- Published by Wiley in HIV Medicine
- Vol. 26 (10) , 1515-1524
Open AccessEuropean Guidelines on HIV and breastfeeding: “Same, same, but different” ‐ Results from a WAVE survey
Introduction: A notable gap exists in research on HIV and breastfeeding in high‐income settings with continuous access to antiretroviral therapy (ART) and suppressed HIV viral loads. The Women Against Viruses in Europe (WAVE) initiative aimed to consolidate European guidelines on HIV and breastfeeding to better inform medical staff and people living with HIV in the decision‐making process for breastfeeding. Methods: Representatives from 23 countries were contacted by WAVE to submit their guidelines on HIV and breastfeeding, translated into English. The initial contact was made on 20 April 2023, and the final response was received on 26 May 2023. The WAVE breastfeeding group summarized the guidelines into key topics related to breastfeeding for the purpose of this manuscript. Results: A total of 19 guidelines from 20 countries were included in the review. While the majority of countries recommend formula feeding as the preferred feeding for infants born to mothers living with HIV, most provide recommendations to support parents who choose to breastfeed if certain criteria are met. Conclusion: Despite recommendations being based on the same research, there is variation across guidelines. This review consolidates European guidelines, enabling us to learn from each other and pool our experiences to create a robust cohort for further research and guideline development for parents living with HIV and their infants.
- 15 May 2018
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 146 (10) , 1301-1307
Comprehensive nationwide analysis of mother-to-child HIV transmission in Finland from 1983 to 2013
HIV-positive children are still born in Europe despite low mother-to-child transmission (MTCT) rates. We aimed to clarify the remaining barriers to the prevention of MTCT. By combining the national registers, we identified all women living with HIV delivering at least one child during 1983–2013. Of the 212 women delivering after HIV diagnosis, 46% were diagnosed during the pregnancy. In multivariate analysis, age >30 years (P= 0.001), sexual transmission (P= 0.012), living outside of the metropolitan area (P= 0.001) and Eastern European origin (P= 0.043) were risk factors for missed diagnosis before pregnancy. The proportion of immigrants increased from 18% before 1999 to 75% during 2011–2013 (P< 0.001). They were diagnosed during the pregnancy equally to natives and achieved similar, good treatment results. No MTCT occurred when the mother was diagnosed before the delivery. In addition, 12 women had delivered in 2 years prior their HIV diagnosis, most before implementation of the national screening of pregnant women. Three of these children were infected, the last one in 2000. Our data demonstrate that complete elimination of MTCT is feasible in a high-income, low-prevalence country. This requires ongoing universal screening in early pregnancy and easy access to antiretroviral therapy to all HIV-positive people.
- 15 May 2018
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 146 (10) , 1301-1307
Comprehensive nationwide analysis of mother-to-child HIV transmission in Finland from 1983 to 2013
HIV-positive children are still born in Europe despite low mother-to-child transmission (MTCT) rates. We aimed to clarify the remaining barriers to the prevention of MTCT. By combining the national registers, we identified all women living with HIV delivering at least one child during 1983–2013. Of the 212 women delivering after HIV diagnosis, 46% were diagnosed during the pregnancy. In multivariate analysis, age >30 years (P= 0.001), sexual transmission (P= 0.012), living outside of the metropolitan area (P= 0.001) and Eastern European origin (P= 0.043) were risk factors for missed diagnosis before pregnancy. The proportion of immigrants increased from 18% before 1999 to 75% during 2011–2013 (P< 0.001). They were diagnosed during the pregnancy equally to natives and achieved similar, good treatment results. No MTCT occurred when the mother was diagnosed before the delivery. In addition, 12 women had delivered in 2 years prior their HIV diagnosis, most before implementation of the national screening of pregnant women. Three of these children were infected, the last one in 2000. Our data demonstrate that complete elimination of MTCT is feasible in a high-income, low-prevalence country. This requires ongoing universal screening in early pregnancy and easy access to antiretroviral therapy to all HIV-positive people.
- Open Access
- 22 March 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (3) , e0194370
Most women living with HIV can deliver vaginally—National data from Finland 1993–2013
Vaginal delivery has been recommended for more than ten years for women living with HIV (WLWH) with good virological control. However, in Europe most WLWH still deliver by cesarean section (CS). Our aim was to assess the rate of vaginal delivery and the indications for CS in WLWH over 20 years in a setting of low overall CS rate. This was a retrospective study of all WLWH delivering in Finland 1993–2013. We identified the women by combining national health registers and extracted data from patient files. The study comprised 212 women with 290 deliveries. Over 35% of the women delivered several children during the study years. During 2000–2013, with consistent viral load monitoring, 80.0% showed HIV viral loads p = 0.024]). No perinatal HIV transmissions occurred. Most WLWH can achieve good virological control and deliver vaginally. This will help them to maintain their future child bearing potential and reduce CS-related morbidity.
- 22 March 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (3) , e0194370
Open AccessMost women living with HIV can deliver vaginally—National data from Finland 1993–2013
Vaginal delivery has been recommended for more than ten years for women living with HIV (WLWH) with good virological control. However, in Europe most WLWH still deliver by cesarean section (CS). Our aim was to assess the rate of vaginal delivery and the indications for CS in WLWH over 20 years in a setting of low overall CS rate. This was a retrospective study of all WLWH delivering in Finland 1993–2013. We identified the women by combining national health registers and extracted data from patient files. The study comprised 212 women with 290 deliveries. Over 35% of the women delivered several children during the study years. During 2000–2013, with consistent viral load monitoring, 80.0% showed HIV viral loads p = 0.024]). No perinatal HIV transmissions occurred. Most WLWH can achieve good virological control and deliver vaginally. This will help them to maintain their future child bearing potential and reduce CS-related morbidity.
- 19 September 2017
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 96 (11) , 1330-1337
Declining prevalence of cytological squamous intraepithelial lesions of the cervix among women living with well‐controlled HIV – Most women living with HIV do not need annual PAP smear screening
Introduction: Cervical screening by means of annual Papanicolaou (PAP) smears has been recommended for all women living with HIV. We analysed the results of our annual PAP smear screening program to identify low‐risk subgroups for less rigorous screening.Material and methods: The study comprised 369 women followed at the Helsinki University Hospital 2002–2013, with a total of 2033 PAP smear results. We analyzed the temporal changes in PAP smear findings. Logistic regression analysis for binominal dependent variables was used for assessing risk factors for ever having cytological squamous intraepithelial lesions (hereafter referred as SIL) using generalized estimating equations taking into account multiple observations of each patient.Results: Most women had well‐controlled HIV, especially towards the end of the study. PAP smear results improved substantially. At the time of each individual's last PAP smear, 90.0% of the findings displayed normal results. Conversely, the rate of SIL decreased from 16.8% to 4.6% from 2002 to 2013. In multivariate analysis the risk of SIL was significantly lower in women with consecutive normal PAP smear findings during the first two years of follow up [odds ratio (OR) 0.21, 95% confidence interval (CI) 0.10–0.45, p < 0.001] and with CD4 counts >500 cells/μL (OR 0.11, 95% CI 0.05–0.26, p < 0.001).Conclusions: Widespread use of combination antiretroviral therapy (cART) and systematic cervical screening has reduced the rate of abnormal PAP smears. It seems feasible to identify low‐risk women by combining HIV‐related information and PAP smear results. Screening low‐risk women living with HIV at three‐year intervals similar to HIV‐negative women appears justified.
- 19 September 2017
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 96 (11) , 1330-1337
Declining prevalence of cytological squamous intraepithelial lesions of the cervix among women living with well‐controlled HIV – Most women living with HIV do not need annual PAP smear screening
Introduction: Cervical screening by means of annual Papanicolaou (PAP) smears has been recommended for all women living with HIV. We analysed the results of our annual PAP smear screening program to identify low‐risk subgroups for less rigorous screening.Material and methods: The study comprised 369 women followed at the Helsinki University Hospital 2002–2013, with a total of 2033 PAP smear results. We analyzed the temporal changes in PAP smear findings. Logistic regression analysis for binominal dependent variables was used for assessing risk factors for ever having cytological squamous intraepithelial lesions (hereafter referred as SIL) using generalized estimating equations taking into account multiple observations of each patient.Results: Most women had well‐controlled HIV, especially towards the end of the study. PAP smear results improved substantially. At the time of each individual's last PAP smear, 90.0% of the findings displayed normal results. Conversely, the rate of SIL decreased from 16.8% to 4.6% from 2002 to 2013. In multivariate analysis the risk of SIL was significantly lower in women with consecutive normal PAP smear findings during the first two years of follow up [odds ratio (OR) 0.21, 95% confidence interval (CI) 0.10–0.45, p < 0.001] and with CD4 counts >500 cells/μL (OR 0.11, 95% CI 0.05–0.26, p < 0.001).Conclusions: Widespread use of combination antiretroviral therapy (cART) and systematic cervical screening has reduced the rate of abnormal PAP smears. It seems feasible to identify low‐risk women by combining HIV‐related information and PAP smear results. Screening low‐risk women living with HIV at three‐year intervals similar to HIV‐negative women appears justified.
- Open Access
- 5 January 2015
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 22 (s1) , 46-73
Strategies to manage hepatitis C virus (HCV) infection disease burden – volume 2
Summary: The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries, and the relative impact of two scenarios was considered: (i) increased treatment efficacy while holding the treated population constant and (ii) increased treatment efficacy and increased annual treated population. Increasing levels of diagnosis and treatment, in combination with improved treatment efficacy, were critical for achieving substantial reductions in disease burden. In most countries, the annual treated population had to increase several fold to achieve the largest reductions in HCV‐related morbidity and mortality. This suggests that increased capacity for screening and treatment will be critical in many countries. Birth cohort screening is a helpful tool for maximizing resources. In most of the studied countries, the majority of patients were born between 1945 and 1985.
- 5 January 2015
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 22 (s1) , 46-73
Open AccessStrategies to manage hepatitis C virus (HCV) infection disease burden – volume 2
Summary: The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries, and the relative impact of two scenarios was considered: (i) increased treatment efficacy while holding the treated population constant and (ii) increased treatment efficacy and increased annual treated population. Increasing levels of diagnosis and treatment, in combination with improved treatment efficacy, were critical for achieving substantial reductions in disease burden. In most countries, the annual treated population had to increase several fold to achieve the largest reductions in HCV‐related morbidity and mortality. This suggests that increased capacity for screening and treatment will be critical in many countries. Birth cohort screening is a helpful tool for maximizing resources. In most of the studied countries, the majority of patients were born between 1945 and 1985.
- Open Access
- 5 January 2015
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 22 (s1) , 6-25
Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 2
Summary: Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.
- 5 January 2015
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 22 (s1) , 6-25
Open AccessHistorical epidemiology of hepatitis C virus (HCV) in select countries – volume 2
Summary: Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.
- Open Access
- 1 January 2015
- Published by Wiley in Journal of the International AIDS Society
- Vol. 18 (1) , 19962
Perception of sexuality and fertility in women living with HIV: a questionnaire study from two Nordic countries
Introduction: As the human immunodeficiency virus (HIV)‐positive population ages, issues concerning sexuality and fertility, among others, are becoming relevant. HIV is still surrounded by stigma and taboos, and there have been few studies conducted in industrialized settings concerning these questions. We therefore wanted to investigate the perception of sexuality and fertility in women living with HIV (WLWH) in an industrialized setting, using a questionnaire.Methods: WLWH were recruited at their regular outpatient clinic visits, at the major Departments of Infectious Diseases in Denmark and Finland, from January 2012 to October 2013. A questionnaire was developed, study participants were informed of the nature of study and, if they agreed to participate and signed a consent form, they filled in the questionnaire. Demographic information on the participants was obtained from patient files (in Finland) or from a national HIV cohort (in Denmark). Statistical analysis was performed using STATA®, version 11.Results: In total, 560 women were included in the study. The median age was 44 years. The majority were of white European origin, with fully suppressed HIV viral load, CD4 cell count >350 µL and mild or no symptoms of their HIV infection. A total of 62% were sexually active, stating condom use as their sole form of contraception. Of the sexually inactive women, one‐third were in steady relationships. Eighty percent reported prior pregnancies, of which the majority had one or more children. Most children were born prior to the women's HIV diagnosis and the mode of conception was predominantly natural. One‐quarter of the participating women desired pregnancy, while more than half did not. The remaining quarter either stated that they already had the desired number of children or chose not to answer the question. Fourteen percent stated that their HIV diagnosis ended their wish for children; of these women, the median time of diagnosis was between 1995 and 1996. Pregnancy had been attempted unsuccessfully in one‐quarter of study participants. The final question inquired what the risk of mother‐to‐child transmission was, with all precautions taken. Fifteen percent estimated the risk to be above two percent.Conclusions: In conclusion, the majority of WLWH in industrialized settings in Denmark and Finland have few HIV‐related symptoms, are sexually active and have a strong desire for children.
- 1 January 2015
- Published by Wiley in Journal of the International AIDS Society
- Vol. 18 (1) , 19962
Open AccessPerception of sexuality and fertility in women living with HIV: a questionnaire study from two Nordic countries
Introduction: As the human immunodeficiency virus (HIV)‐positive population ages, issues concerning sexuality and fertility, among others, are becoming relevant. HIV is still surrounded by stigma and taboos, and there have been few studies conducted in industrialized settings concerning these questions. We therefore wanted to investigate the perception of sexuality and fertility in women living with HIV (WLWH) in an industrialized setting, using a questionnaire.Methods: WLWH were recruited at their regular outpatient clinic visits, at the major Departments of Infectious Diseases in Denmark and Finland, from January 2012 to October 2013. A questionnaire was developed, study participants were informed of the nature of study and, if they agreed to participate and signed a consent form, they filled in the questionnaire. Demographic information on the participants was obtained from patient files (in Finland) or from a national HIV cohort (in Denmark). Statistical analysis was performed using STATA®, version 11.Results: In total, 560 women were included in the study. The median age was 44 years. The majority were of white European origin, with fully suppressed HIV viral load, CD4 cell count >350 µL and mild or no symptoms of their HIV infection. A total of 62% were sexually active, stating condom use as their sole form of contraception. Of the sexually inactive women, one‐third were in steady relationships. Eighty percent reported prior pregnancies, of which the majority had one or more children. Most children were born prior to the women's HIV diagnosis and the mode of conception was predominantly natural. One‐quarter of the participating women desired pregnancy, while more than half did not. The remaining quarter either stated that they already had the desired number of children or chose not to answer the question. Fourteen percent stated that their HIV diagnosis ended their wish for children; of these women, the median time of diagnosis was between 1995 and 1996. Pregnancy had been attempted unsuccessfully in one‐quarter of study participants. The final question inquired what the risk of mother‐to‐child transmission was, with all precautions taken. Fifteen percent estimated the risk to be above two percent.Conclusions: In conclusion, the majority of WLWH in industrialized settings in Denmark and Finland have few HIV‐related symptoms, are sexually active and have a strong desire for children.
- Open Access
- 11 November 2012
- Published by Wiley in Journal of the International AIDS Society
- Vol. 15 (6)
Comprehensive care with antiretroviral therapy for injecting-drug users associates to low community viral load and restriction of HIV outbreak
- 11 November 2012
- Published by Wiley in Journal of the International AIDS Society
- Vol. 15 (6)
Open AccessComprehensive care with antiretroviral therapy for injecting-drug users associates to low community viral load and restriction of HIV outbreak